American Journal of Psychiatry
- Volume 165
- Number 5
- May 2008
In This Issue
Editorial
Images in Neuroscience
Introspections
Treatment in Psychiatry
Clinical Case Conference
Images in Psychiatry
Reviews and Overviews
Publication date: 01 May 2008
Pages579–587Objective: Over the past three decades, there have been significant changes in the diagnostic criteria for schizophrenia as well as changes in measurement of IQ. The last quantitative review of the literature on premorbid IQ in schizophrenia ...
https://doi.org/10.1176/appi.ajp.2008.07081242Article
Publication date: 01 May 2008
Pages588–596Objective: While the evidence base for treatments for adolescent depression is building, little is known about the relative efficiency of such treatments. Treatment costs are a relevant concern given the competing demands on family and health ...
https://doi.org/10.1176/appi.ajp.2008.07101610Publication date: 01 May 2008
Pages597–603Objective: The extant literature does not provide definite answers pertaining to whether stimulant treatment increases, decreases, or does not affect the risk for subsequent substance use disorders in youths with attention deficit hyperactivity ...
https://doi.org/10.1176/appi.ajp.2007.07091486Publication date: 01 May 2008
Pages604–609Objective: Animal studies have shown that age at stimulant exposure is positively related to later drug sensitivity. The purpose of this study was to examine whether age at initiation of stimulant treatment in children with attention deficit ...
https://doi.org/10.1176/appi.ajp.2008.07091465Publication date: 01 May 2008
Pages610–616Objective: Genome scans have revealed significant evidence for linkage of depression to chromosome 15q25.3-q26.2. The gene for neurotrophic tyrosine kinase receptor 3 ( NTRK3 ), the receptor for neurotrophin-3 (trkC) and a ...
https://doi.org/10.1176/appi.ajp.2007.07050805Publication date: 01 May 2008
Pages617–620Objective: The corticotropin-releasing hormone (CRH) system is implicated in the pathogenesis of several psychiatric disorders, including major depressive disorder. This study was designed to evaluate the safety and efficacy of CP-316,311, a ...
https://doi.org/10.1176/appi.ajp.2008.07071199Publication date: 01 May 2008
Pages621–630Objective: Although serotonin reuptake inhibitors (SRIs) are approved for the treatment of obsessive-compulsive disorder (OCD), most OCD patients who have received an adequate SRI trial continue to have clinically significant OCD symptoms. The ...
https://doi.org/10.1176/appi.ajp.2007.07091440Publication date: 01 May 2008
Pages631–638Objective: This study evaluated the effect of mentalization-based treatment by partial hospitalization compared to treatment as usual for borderline personality disorder 8 years after entry into a randomized, controlled trial and 5 years after ...
https://doi.org/10.1176/appi.ajp.2007.07040636Publication date: 01 May 2008
Pages639–645Objective: Studies of emotion recognition abilities in schizophrenia show greater impairment for non-Caucasians with schizophrenia compared with Caucasians. These studies, however, included only Caucasian faces as stimuli. There is evidence ...
https://doi.org/10.1176/appi.ajp.2007.07101604Letters to the Editor
Correction
Book Forum
Books Received
Past Issues
View Issues Archive
Vol. 181 | No. 11
Vol. 181 | No. 10
Vol. 181 | No. 9
